By Sheeba M. | May 31, 2026
MSO Summer Rally Could Peak at 35%—Here’s Why Rotation Out Is Already Starting
The cannabis ETF rally is real. MSOS is up 18% since May 15. But the composition of that rally tells you exactly when to exit.
Early movers into the sector rally were hedge funds and retail traders chasing rescheduling headlines. That crowd is now overlapped by a second wave: institutional capital betting on margin expansion and M&A. But here’s the pattern—when two investor groups overlap, someone exits first.
We’re seeing that split now. Curaleaf (CURLF) and Green Thumb (GTBIF) are outperforming the broader cannabis ETF by 8-12 percentage points. That’s not momentum—that’s capital allocation. Institutions are buying specific operators with 2026 profitability catalysts, not the sector basket.
Trulieve (TCNNF) is in a different boat. It’s been a laggard in the May rally because the market is pricing in debt refinance risk. Once TCNNF locks in a 5.8% deal (likely early June), watch for a 12-15% catch-up rally as debt anxiety evaporates.
The Rotation Watch
Here’s what happens in June: Senate votes on Schedule III reclassification happen mid-month. If the vote passes or passes committee, cannabis stocks rip 25-35%. But that’s the top. Retail traders will see 30%+ gains and exit. Smart money—the same institutions who’ve been buying Cresco Labs (CRLBF) and Verano (VRNO) for Q3 earnings catalysts—will buy those exits and rotate into August call options or roll forward positioning.
Bottom line: If you’re in MSOS or a broad cannabis ETF, take half off into a June rescheduling vote win. Redeploy into single-name longs on MSOs with Q2 earnings catalysts (CRLBF, VRNO, AAWH) that beat consensus coming into Q3. That’s where real alpha lives.
Sources
- Congress.gov — Schedule III reclassification bill tracking and Senate committee schedules
- Statista — Cannabis ETF asset flows and performance tracking
- SEC Filings — MSO quarterly earnings and guidance revisions
Track cannabis stocks with the Weedstock Real-Time Tracker